221 related articles for article (PubMed ID: 26806351)
1. Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding.
Roblek M; Strutzmann E; Zankl C; Adage T; Heikenwalder M; Atlic A; Weis R; Kungl A; Borsig L
Neoplasia; 2016 Jan; 18(1):49-59. PubMed ID: 26806351
[TBL] [Abstract][Full Text] [Related]
2. CCL2 Is a Vascular Permeability Factor Inducing CCR2-Dependent Endothelial Retraction during Lung Metastasis.
Roblek M; Protsyuk D; Becker PF; Stefanescu C; Gorzelanny C; Glaus Garzon JF; Knopfova L; Heikenwalder M; Luckow B; Schneider SW; Borsig L
Mol Cancer Res; 2019 Mar; 17(3):783-793. PubMed ID: 30552233
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of CCR2 antagonist to activated pulmonary endothelium prevents metastasis.
Roblek M; Calin M; Schlesinger M; Stan D; Zeisig R; Simionescu M; Bendas G; Borsig L
J Control Release; 2015 Dec; 220(Pt A):341-347. PubMed ID: 26522070
[TBL] [Abstract][Full Text] [Related]
4. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.
Qian BZ; Li J; Zhang H; Kitamura T; Zhang J; Campion LR; Kaiser EA; Snyder LA; Pollard JW
Nature; 2011 Jun; 475(7355):222-5. PubMed ID: 21654748
[TBL] [Abstract][Full Text] [Related]
5. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.
Han R; Gu S; Zhang Y; Luo A; Jing X; Zhao L; Zhao X; Zhang L
Sci Rep; 2018 Jun; 8(1):9575. PubMed ID: 29934505
[TBL] [Abstract][Full Text] [Related]
6. Designing a mutant CCL2-HSA chimera with high glycosaminoglycan-binding affinity and selectivity.
Gerlza T; Winkler S; Atlic A; Zankl C; Konya V; Kitic N; Strutzmann E; Knebl K; Adage T; Heinemann A; Weis R; Kungl AJ
Protein Eng Des Sel; 2015 Aug; 28(8):231-40. PubMed ID: 25969511
[TBL] [Abstract][Full Text] [Related]
7. Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathway.
Wolf MJ; Hoos A; Bauer J; Boettcher S; Knust M; Weber A; Simonavicius N; Schneider C; Lang M; Stürzl M; Croner RS; Konrad A; Manz MG; Moch H; Aguzzi A; van Loo G; Pasparakis M; Prinz M; Borsig L; Heikenwalder M
Cancer Cell; 2012 Jul; 22(1):91-105. PubMed ID: 22789541
[TBL] [Abstract][Full Text] [Related]
8. Targeting the CCL2-CCR2 signaling axis in cancer metastasis.
Lim SY; Yuzhalin AE; Gordon-Weeks AN; Muschel RJ
Oncotarget; 2016 May; 7(19):28697-710. PubMed ID: 26885690
[TBL] [Abstract][Full Text] [Related]
9. Chronic psychological stress promotes lung metastatic colonization of circulating breast cancer cells by decorating a pre-metastatic niche through activating β-adrenergic signaling.
Chen H; Liu D; Guo L; Cheng X; Guo N; Shi M
J Pathol; 2018 Jan; 244(1):49-60. PubMed ID: 28940209
[TBL] [Abstract][Full Text] [Related]
10. CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels.
Maus UA; Wellmann S; Hampl C; Kuziel WA; Srivastava M; Mack M; Everhart MB; Blackwell TS; Christman JW; Schlöndorff D; Bohle RM; Seeger W; Lohmeyer J
Am J Physiol Lung Cell Mol Physiol; 2005 Feb; 288(2):L350-8. PubMed ID: 15516494
[TBL] [Abstract][Full Text] [Related]
11. CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms.
Fang WB; Jokar I; Zou A; Lambert D; Dendukuri P; Cheng N
J Biol Chem; 2012 Oct; 287(43):36593-608. PubMed ID: 22927430
[TBL] [Abstract][Full Text] [Related]
12. Gas6 Promotes Inflammatory (CCR2
Laurance S; Bertin FR; Ebrahimian T; Kassim Y; Rys RN; Lehoux S; Lemarié CA; Blostein MD
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1315-1322. PubMed ID: 28450294
[TBL] [Abstract][Full Text] [Related]
13. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
[TBL] [Abstract][Full Text] [Related]
14. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis.
Izhak L; Wildbaum G; Jung S; Stein A; Shaked Y; Karin N
PLoS One; 2012; 7(1):e28305. PubMed ID: 22279523
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Radiation-Induced Ccl2 Signaling Protects Lungs from Vascular Dysfunction and Endothelial Cell Loss.
Wiesemann A; Ketteler J; Slama A; Wirsdörfer F; Hager T; Röck K; Engel DR; Fischer JW; Aigner C; Jendrossek V; Klein D
Antioxid Redox Signal; 2019 Jan; 30(2):213-231. PubMed ID: 29463096
[No Abstract] [Full Text] [Related]
17. Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting.
Xu M; Wang Y; Xia R; Wei Y; Wei X
Cell Prolif; 2021 Oct; 54(10):e13115. PubMed ID: 34464477
[TBL] [Abstract][Full Text] [Related]
18. TCF4 enhances hepatic metastasis of colorectal cancer by regulating tumor-associated macrophage via CCL2/CCR2 signaling.
Tu W; Gong J; Zhou Z; Tian D; Wang Z
Cell Death Dis; 2021 Sep; 12(10):882. PubMed ID: 34580284
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.
Sanford DE; Belt BA; Panni RZ; Mayer A; Deshpande AD; Carpenter D; Mitchem JB; Plambeck-Suess SM; Worley LA; Goetz BD; Wang-Gillam A; Eberlein TJ; Denardo DG; Goedegebuure SP; Linehan DC
Clin Cancer Res; 2013 Jul; 19(13):3404-15. PubMed ID: 23653148
[TBL] [Abstract][Full Text] [Related]
20. CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway.
Zhuang H; Cao G; Kou C; Liu T
Oncol Rep; 2018 Jan; 39(1):21-30. PubMed ID: 29115520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
